CompletedPhase 3NCT00011362

Dexamethasone Therapy in VLBW Infants at Risk of CLD

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov May 5, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: NICHD Neonatal Research Network
Principal Investigator: Lu-Ann Papile, MD
University of New Mexico
Intervention: Dexamethasone Early(drug)
Enrollment: 371 enrolled
Eligibility: All sexes
Timeline: 1992 – 1994

Study locations (13)

Stanford University, Palo Alto, California, United States
Yale University, New Haven, Connecticut, United States
George Washington University, Washington D.C., District of Columbia, United States
University of Miami, Miami, Florida, United States
Emory University, Atlanta, Georgia, United States
Indiana University, Indianapolis, Indiana, United States
Wayne State University, Detroit, Michigan, United States
University of New Mexico, Albuquerque, New Mexico, United States
Cincinnati Children's Medical Center, Cincinnati, Ohio, United States
Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States
Brown University, Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States
University of Tennessee, Memphis, Tennessee, United States
University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States

Collaborators

National Center for Research Resources (NCRR)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00011362 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia →

← Back to all trials